Does low estradiol matter for men’s bone, vascular, metabolic, and sexual health?

Estradiol is a critical, non-redundant regulator of male physiological health. For older men, maintaining adequate estradiol levels is vital for skeletal, cardiovascular, metabolic, and sexual function.

Clinical and preventive evidence

• Skeletal protection: Data from major prospective cohorts, including the Osteoporotic Fractures in Men (MrOS) study, indicate that estradiol levels below 20 to 25 pg/mL are strongly associated with accelerated bone mineral density loss and a significantly elevated risk of hip fractures, independent of testosterone levels.
• Vitality and sexual function: Estradiol levels below 20 pg/mL are clinically linked to somatic complaints such as joint pain, fatigue, and cognitive changes. Furthermore, suppressing estrogen synthesis independently impairs libido and erectile function, demonstrating that estradiol is necessary alongside testosterone to maintain sexual vitality.

Mechanistic pathways

• Vascular function: Aromatase conversion of testosterone to estradiol is essential for endothelial health. Lowering estradiol impairs flow-mediated dilation (FMD)—a direct measure of nitric oxide-dependent endothelial function—although its impact on systemic arterial compliance remains minimal.
• Metabolic regulation: Estradiol protects against metabolic dysfunction by signaling through estrogen receptors (ERα and ERβ) in key metabolic tissues. This receptor activation is crucial for maintaining insulin sensitivity and preventing the accumulation of visceral adiposity.

Bottom line

• Estradiol levels below 20 to 25 pg/mL in men significantly compromise bone density, elevate fracture risk, and impair subjective vitality. Maintaining a mid-physiologic range of 20 to 40 pg/mL is key to supporting cardiovascular, metabolic, and skeletal health in aging men.